Summary

Eligibility
for males ages 18-45 (full criteria)
Location
at Los Angeles, California
Dates
study started
completion around
Principal Investigator
by Daniel Lu, MD, PhD

Description

Summary

This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury.

Details

This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury. Neuromodulation will be in the form of transcutaneous electrical stimulation and/or magnetic stimulation.

Keywords

Spinal Cord Injury, Spinal Cord Injuries, Electromagnetic Neuromodulation, Stimulation of Non-Naive, Stimulation of Naive, Stimulation

Eligibility

You can join if…

Open to males ages 18-45

  1. Male 18-45 years;
  2. At least 1 year post-injury;
  3. Non-progressive SCI at C2-T8 (non-conus injury);
  4. Motor Complete ASIA (A or B);
  5. Neurogenic bladder requiring clean intermittent straight catheterization;
  6. Able to attend twice weekly testing sessions for 6 months.
  7. Have intact lower extremity anatomy and able to use lower extremity for assistive standing and stepping.

You CAN'T join if...

  1. History of autonomic dysreflexia;
  2. Ventilator dependency;
  3. Musculoskeletal dysfunction, unhealed fracture, pressure ulcer, active infection;
  4. Clinically significant depression or ongoing drug abuse;
  5. Received botox injection, or bladder surgery (suprapubic access, Brindley procedure, etc.); 6. Prostatic hypertrophy or bladder outlet disorder;
  6. Cardiopulmonary disease that precludes lower extremity training or rehabilitation.

Location

  • University of California, Los Angeles accepting new patients
    Los Angeles California 90095 United States

Lead Scientist at UCLA

  • Daniel Lu, MD, PhD
    Professor, Neurosurgery, Medicine. Authored (or co-authored) 100 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT02331979
Study Type
Interventional
Participants
Expecting 24 study participants
Last Updated